Effectiveness and Safety of ArcBlate Palliative Treatment for Patients With Painful Bone Metastases: A Pivotal Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEpiSonica

About this trial

A Pivotal Study to Evaluate the Effectiveness and Safety of ArcBlate Palliative Treatment for Patients With Painful Bone Metastases

Eligibility criteria

Qualifiers

Men and women aged 18 and older.

Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 at enrollment.

Patients who are able and willing to give consent and able to attend all study visits.

Patients who are suffering from painful bone metastases.

Disqualifiers

need surgical stabilization of the affected bony structure (>7 fracture risk score), Or

targeted tumor is at an impending fracture site (>7 on fracture risk score), Or

patients with surgical stabilization of tumor site with metallic hardware. (2) Targeted (treated) lesion is in the skull. (3) Patients on dialysis. (4) Patients with life expectancy < 3-Months. (5) Patients with an acute medical condition (e.g., pneumonia, sepsis) that is expected to hinder them from completing this study.

Unstable angina pectoris on medication,

Trial design

Treatments tested in this trial

  • ArcBlate Focused Ultrasound Ablation System
  • Sham MRgHIFU treatment

Treatment groups

100 Participants
are divided into 2 treatment groups

Locations

4
Far Eastern Memorial Hospital220, New Taipei City Taiwan
Taichung Veterans General Hospital407, Taichung Taiwan
National Taiwan University Hospital100, Taipei Taiwan
Chang Gung Memorial Hospital - Linkou333, Taoyuan Taiwan

Sponsors and collaborators

EpiSonica

Lead sponsor